NYSE:LOW • US5486611073
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LOWE'S COS INC (LOW).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-27 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-26 | TD Cowen | Maintains | Hold -> Hold |
| 2026-02-26 | Bernstein | Maintains | Outperform -> Outperform |
| 2026-02-26 | DA Davidson | Maintains | Neutral -> Neutral |
| 2026-02-26 | UBS | Maintains | Buy -> Buy |
| 2026-02-26 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-26 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2026-02-26 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-26 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-26 | Truist Securities | Maintains | Buy -> Buy |
| 2026-02-26 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2026-02-23 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-18 | Bernstein | Maintains | Outperform -> Outperform |
| 2026-02-18 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2026-02-12 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-20 | TD Cowen | Maintains | Hold -> Hold |
| 2026-01-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-13 | Gordon Haskett | Upgrade | Hold -> Buy |
| 2026-01-07 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-12-05 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-12-01 | Stifel | Maintains | Hold -> Hold |
| 2025-11-20 | Bernstein | Maintains | Outperform -> Outperform |
| 2025-11-20 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-20 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-11-20 | UBS | Maintains | Buy -> Buy |
| 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 86.377B -11.01% | 83.674B -3.13% | 86.286B 3.12% | 94.209B 9.18% | 97.557B 3.55% | 101.275B 3.81% | 102.497B 1.21% | 106.323B 3.73% | 115.01B 8.17% | 119.412B 3.83% | 123.979B 3.82% | |
| EBITDA YoY % growth | 13.401B 10.39% | 12.261B -8.51% | 12.347B 0.70% | 13.347B 8.10% | 14.038B 5.18% | 14.593B 3.95% | 14.994B 2.75% | 15.682B 4.59% | 17.08B 8.91% | 18.017B 5.49% | 19.187B 6.49% | |
| EBIT YoY % growth | 11.478B 12.98% | 10.289B -10.36% | 10.153B -1.32% | 11.215B 10.46% | 11.884B 5.97% | 12.525B 5.39% | 12.936B 3.28% | 13.546B 4.72% | 15.041B 11.04% | 15.989B 6.30% | 17.076B 6.80% | |
| Operating Margin | 13.29% | 12.30% | 11.77% | 11.90% | 12.18% | 12.37% | 12.62% | 12.74% | 13.08% | 13.39% | 13.77% | |
| EPS YoY % growth | 13.06 -4.88% | 11.98 -8.27% | N/A 3.37% | 13.08 5.63% | 14.18 8.44% | 15.58 9.80% | 16.91 8.58% | 18.46 9.17% | 21.28 15.26% | 23.39 9.92% | 26.01 11.18% |
All data in USD
| Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.11 6.65% | 4.53 4.71% | 3.25 6.21% | 2.12 8.10% | 3.36 8.00% | 4.61 1.59% | 3.25 0.07% | 2.64 24.30% |
| Revenue Q2Q % growth | 23.439B 11.99% | 26.529B 10.73% | 22.891B 9.98% | 21.201B 3.00% | 23.958B 2.21% | 27.21B 2.57% | 24.07B 5.15% | 21.894B 3.27% |
| EBITDA Q2Q % growth | 3.217B 7.20% | 4.257B -6.11% | 3.33B -20.09% | 2.537B -34.98% | 3.539B 10.01% | 4.41B 3.59% | 3.381B 1.53% | 2.901B 14.35% |
| EBIT Q2Q % growth | 2.69B 7.86% | 3.75B 6.78% | 2.803B 7.39% | 1.967B 15.16% | 2.863B 6.43% | 3.794B 1.17% | 2.765B -1.36% | 2.295B 16.68% |
All data in USD
40 analysts have analysed LOW and the average price target is 288.9 USD. This implies a price increase of 11.71% is expected in the next year compared to the current price of 258.62.
LOWE'S COS INC (LOW) will report earnings on 2026-05-19, before the market open.
The consensus EPS estimate for the next earnings of LOWE'S COS INC (LOW) is 3.11 USD and the consensus revenue estimate is 23.44B USD.
The consensus rating for LOWE'S COS INC (LOW) is 78 / 100 . This indicates that analysts generally have a positive outlook on the stock.